A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)
Condition: Type 2 Diabetes Mellitus (T2DM) · Sponsor: Amgen
About this study
The main purpose of this study is to assess the dose-response relationship of maridebart cafraglutide on glucose control compared with placebo.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (96)
| Accel Research Site - Birmingham Clinical Research Unit | Birmingham, Alabama, United States | — |
| Anaheim Clinical Trials | Anaheim, California, United States | — |
| Hope Clinical Research LLC | Canoga Park, California, United States | — |
| Orange County Research Center | Lake Forest, California, United States | — |
| San Jose Clinical Trials | San Jose, California, United States | — |
| Northeast Research Institute - Neri | Fleming Island, Florida, United States | — |
| New Horizon Research Center | Miami, Florida, United States | — |
| Florida Institute for Clinical Research | Orlando, Florida, United States | — |
| Conquest Research - Winter Park | Winter Park, Florida, United States | — |
| Accel Research Site - Neurostudies | Decatur, Georgia, United States | — |
| Cedar Crosse Research and Health Care | Chicago, Illinois, United States | — |
| Tandem Clinical Research - Marrero | Marrero, Louisiana, United States | — |
+ 84 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06660173